Packard Center researcher and Rothstein lab member chosen as a 2023 ALS Association Milton Safenowitz Postdoctoral Fellow
Congratulations to S. Can Akerman, Ph.D, a member of the Rothstein Lab, a member of the Packard Center community of researchers and a postdoctoral fellow at Johns Hopkins University for being selected selected to join The ALS Association’s 2023 Class of Milton Safenowitz Postdoctoral Fellows.
Five bright, young researchers from prestigious academic institutions across the country have been selected to join The ALS Association’s 2023 Class of Milton Safenowitz Postdoctoral Fellows.
Established in 2004 in memory of Milton Safenowitz by the Safenowitz family, this well-respected program encourages researchers at the very beginning of their careers to enter and, importantly, remain in the ALS field. After completing this fellowship, more than 75% of awardees stay in ALS research, and many go on to establish their own laboratories and mentor more ALS researchers along the way.
“Over the past 20 years, our Safenowitz Postdoctoral Fellowship Program has helped more than 90 promising young scientists establish themselves as part of the ALS research community,” said Paul Larkin, Ph.D., director of research at The ALS Association. “We are excited to welcome five more talented postdocs into this prestigious group and see how they contribute to our understanding of the disease and the search for new treatments and a cure.”
S. Can Akerman, Ph.D., from Johns Hopkins University; Annie Collins, B.M. B.Ch., from UMass Chan Medical School; Mario Flores, M.D., Ph.D., from Harvard’s T. H. Chan School of Public Health; Alexander Lin-Moore, Ph.D., from Brown University; and Sitao Zhang, Ph.D., from the University of California San Diego, were selected from a highly competitive group of applicants based on their professional accomplishments and the high scientific merit of their proposals. They will each receive $150,000 over the next two years to support their projects and professional development.
Read more about the Milton Safenowitz Postdoctoral Fellows.
Reprinted from the ALS Association